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Saccharide–RNA recognition in a complex formed between
neomycin B and an RNA aptamer
Licong Jiang, Ananya Majumdar, Weidong Hu, TJ Jaishree, Weijun Xu 
and Dinshaw J Patel*
Background: Aminoglycoside antibiotics can target RNA folds with micromolar
affinity and inhibit biological processes ranging from protein biosynthesis to
ribozyme action and viral replication. Specific features of aminoglycoside
antibiotic–RNA recognition have been probed using chemical, biochemical,
spectroscopic and computational approaches on both natural RNA targets and
RNA aptamers identified through in vitro selection. Our previous studies on
tobramycin–RNA aptamer complexes are extended to neomycin B bound to its
selected RNA aptamer with 100 nM affinity.
Results: The neamine moiety (rings I and II) of neomycin B is sandwiched
between the major groove floor of a ‘zippered-up’ G•U mismatch aligned
segment and a looped-out purine base that flaps over the bound antibiotic.
Specific intermolecular hydrogen bonds are observed between the charged
amines of neomycin B and base mismatch edges and backbone phosphates.
These interactions anchor 2-deoxystreptamine ring I and pyranose ring II within
the RNA-binding pocket.
Conclusions: The RNA aptamer complexes with tobramycin and neomycin B
utilize common architectural principles to generate RNA-binding pockets for
the bound aminoglycoside antibiotics. In each case, the 2-deoxystreptamine
ring I and an attached pyranose ring are encapsulated within the major
groove binding pocket, which is lined with mismatch pairs. The bound
antibiotic within the pocket is capped over by a looped-out base and
anchored in place through intermolecular hydrogen bonds involving charged
amine groups of the antibiotic.
Introduction
Aminoglycoside antibiotics are the oldest known class of
broad-spectrum antibacterial agents with activity against
Gram-positive and Gram-negative organisms, as well as
mycobacteria. These antibiotics are versatile polycationic
molecules containing aminosugars glycosidically linked to
aminocyclitols. The aminoglycoside antibiotics have been
classified into two subgroups depending on whether the
aminocyclitol is of the streptidine or 2-deoxystreptamine
class. The latter class of antibiotics is further classified
according to the linkage of amino sugars to the non-sugar
2-deoxystreptamine ring. Tobramycin (Figure 1a), which
belongs to the kanamycin subgroup of antibiotics, has
pyranose sugars attached at the 4 and 6 positions of the 
2-deoxystreptamine ring. Neomycin B (Figure 1b), which
together with paromomycin and lividomycin belongs to a
separate subgroup, has a pyranose sugar attached to the 4
position and a furanose–pyranose pair of sugars attached to
the 5 position of the 2-deoxystreptamine ring. The amino-
glycoside antibiotics target a variety of sites on RNA and
in so doing inhibit RNA-mediated biological function
(reviewed in [1–3]). 
The neomycin family of antibiotics have been shown to
bind to the A-site on 16S ribosomal RNA and cause inhibi-
tion of protein biosynthesis [4,5]. Solution structural
studies have defined the saccharide–RNA interface in
complexes between a domain modeled on the 16S rRNA
A-site bound to paromomycin [6] and neomycin B [7].
The characterization of the adaptive structural transition
in the A-site RNA target on complex formation with paro-
momycin [8] has provided insights into the origin of
antibiotic-induced miscoding and resistance mechanisms. 
Neomycin B has also been shown to inhibit the function of
group I [9,10], hammerhead [11,12] and human hepatitis
delta virus [13] ribozymes. The majority of the amine
groups on the aminoglycoside antibiotics are positively
charged at neutral pH and could compete for Mg2+ ions
site-specifically located on the RNA tertiary fold, as pro-
posed for the hammerhead ribozyme [12]. More recent
experimental [14,15] and computational [16,17] approaches
on the hammerhead ribozyme system indeed support this
view [12]. The specificity of aminoglycoside–RNA target
recognition appears to be associated with electrostatic
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complementarity between the positively charged ammo-
nium groups and the negatively charged divalent cation
binding RNA pockets on the hammerhead ribozyme.
Aminoglycoside antibiotics are also known to target human
immunodeficiency virus 1 (HIV-1) TAR RNA, resulting in
the inhibition of regulatory Tat protein–TAR RNA inter-
actions [18], and HIV-1 Rev response element (RRE)
RNA, resulting in the inhibition of regulatory Rev
protein–RRE RNA interactions [19]. 
We have an ongoing program to characterize the solution
structures of aminoglycoside antibiotics bound with high
affinity and specificity to RNA aptamer targets identified
through in vitro selection. Such efforts should provide
insights into the principles, patterns and diversity associ-
ated with saccharide–RNA recognition. Our initial efforts
focused on the solution structures of two tobramycin–RNA
aptamer complexes [20,21] shown previously to bind with
binding constants approaching 10 nM affinity [22]. The
bound tobramycin in these complexes targeted a mis-
match/bulge-aligned major groove RNA-binding pocket
and was partially encapsulated between a flap base and the
floor of the major groove. The complex was also anchored
in position through potential hydrogen-bonding and elec-
trostatic interactions between the charged amine groups
on the antibiotic and the base pair edges and backbone
phosphate of the RNA-binding pocket. 
We report here the solution structure of the complex
between neomycin B (Figure 1b) and an RNA aptamer
(Figure 1c) identified through in vitro selection to bind with
100 nM affinity [23]. This result should allow us to compare
the solution structures of neomycin B bound to its internal
loop A-site domain on 16S rRNA [7] and a stem-loop site in
the RNA aptamer. Further, it should allow the comparison
of the principles and patterns associated with the recogni-
tion by stem-loop RNA aptamers of the tobramycin [20,21]
and neomycin class of aminoglycoside antibiotics. Our
drawing of neomycin B (Figure 1b) has ring IV attached
through an equatorial linkage to ring III rather than the
axial linkage more commonly found in the literature. The
strong nuclear Overhauser effect (NOE) between the H1′′′
and H5′′′ protons on ring IV in a short mixing time NOESY
data set of the complex is consistent with an axial alignment
of these protons (Figure 1b) in the bound neomycin B. The
equatorial glycosidic linkage alignment for ring IV shown in
Figure 1b is also consistent with heteronuclear NMR data
published previously [24,25].
Results
Complex formation
We have monitored formation of the complex between
neomycin B and the RNA aptamer by recording the imino
proton NMR spectrum of free RNA aptamer on gradual
addition of neomycin B. We observe narrow and partially
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Figure 1
Chemical formulae and imino proton spectra.
Chemical formula and numbering system of
(a) tobramycin and (b) neomycin B.
(c) Sequence and numbering system of the
23-mer RNA aptamer. Imino proton NMR
spectra (9.7 to 14.9 ppm) of (d) the free RNA
aptamer, (e) the aptamer on addition of one
equivalent of neomycin B and (f) the aptamer
following the addition of a second equivalent of
neomycin B in H2O buffer (10 mM phosphate)
at pH 6.1 and 5°C. The imino proton
assignments are indicated above the spectra.
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Structure
resolved imino protons (9.5 to 15.0 ppm) for the free RNA
aptamer in H2O buffer, pH 6.1 at 5°C (Figure 1d). These
exchangeable protons have been assigned following analy-
sis of NOESY data sets to guanine and uracil imino
protons forming G•C and A•U Watson–Crick base pairs in
the stem segment, as well as three G•U mismatch pairs
and one Watson–Crick G•C pair in the zippered-up
hairpin loop segment. The imino protons (9.5 to 15.0
ppm) remain narrow following addition of one equivalent
of neomycin B, with the spectrum characterized by down-
field complexation shifts primarily for the imino protons of
G9, G10, G13, G18, U19 and U20 (Figure 1e). These
downfield shifted imino protons are located in the mis-
match segment of the RNA aptamer of the complex. The
free and bound forms during the addition of the first
equivalent are in slow exchange at 5°C. The addition of a
second equivalent of neomycin B results in further down-
field shifts, and also in the slow exchange of the imino
protons of G4, G5, U8 and U24 (as shown in Figure 1f).
These downfield shifted imino protons are located in the
stem segment of the RNA aptamer in the complex.
Proton assignments 
We have assigned the exchangeable RNA protons in the
complex following recording of NOESY data sets as a
function of mixing time supplemented by two-dimen-
sional versions of 1H-13C and 1H-15N heteronuclear multi-
ple quantum coherence (HMQC)-NOESY data sets in
H2O buffer, pH 6.1 at 5°C. The observed NOE and 2JNN
scalar coupling [26,27] patterns confirm formation of
Watson–Crick A•U and G•C pairs in the stem segments, as
well as a Watson–Crick G8•C12 pair and G9•U21,
G10•U20, G11•U19 and sheared G13•A17 mismatch pairs
in the zippered-up hairpin loop segment of the complex. 
The nonexchangeable protons of the bound RNA
aptamer have been assigned following analysis of
NOESY data sets as a function of mixing time supple-
mented by heteronuclear 1H-13C NOESY-HMQC and
1H, 13C, 13C, 1H correlation spectroscopy-total correlation
spectroscopy  (HCCH-COSY-TOCSY) [28] experiments
on the neomycin-B–RNA aptamer complex in D2O
buffer, pH 6.1 at 25°C. An expanded NOESY (300 ms
mixing time) contour plot tracing NOE connectivities
between the base protons (6.8 to 8.8 ppm) and their own
and 5′-flanking sugar H1′ protons (4.0 to 6.4 ppm) from
G4 to C26 is plotted in Figure 2a. The sequential
base–sugar proton connectivities can be readily moni-
tored except for breaks within the G15-A16-A17 segment
(Figure 2a) at the tip of the RNA hairpin loop in the
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Figure 2
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NOESY contour plots obtained for the neomycin-B–RNA aptamer
complex. (a) An expanded NOESY (300 ms mixing time) contour plot
identifying NOEs between the base protons (6.8 to 8.8 ppm) and the
sugar H1′ protons (4.1 to 6.3 ppm) of the neomycin-B–RNA aptamer
complex in D2O buffer, pH 6.1 at 25°C. The lines trace the NOE
connectivities between the base proton and its own and 5′-flanking
sugar H1′ protons for the entire RNA sequence. The strong H5–H6
NOE cross-peaks of the pyrimidines are designated by asterisks.
(b) An expanded NOESY (180 ms mixing time) contour plot identifying
intermolecular NOEs of imino protons (10.0 to 12.8 ppm) and
neomycin B protons (1.65–3.90 ppm) in the neomycin-B–RNA
aptamer complex in H2O buffer at pH 6.1 and 5°C. (c) An expanded
NOESY (300 ms mixing time) contour plot identifying intermolecular
NOEs of base protons (8.1 to 8.8 ppm) and neomycin B protons (1.65
to 3.90 ppm) in the neomycin-B–RNA aptamer complex in H2O buffer
at pH 6.1 and 5°C.
complex. Further, all residues adopt anti glycosidic
torsion angles in the complex.
The majority of the phosphorus resonances in the
neomycin-B–RNA aptamer complex are dispersed
between –3.5 and –5.0 ppm relative to standard
trimethylphosphate. The three phosphorus resonances
shifted outside this region resonate at –1.35, –3.14 and
–6.23 ppm and have been assigned from an analysis of a
1H-31P correlation experiment to the phosphates at the
G13-A14, A14-G15 and G15-A16 steps, respectively. 
The bound neomycin B protons have been assigned fol-
lowing analysis of COSY, TOCSY and NOESY experi-
ments on the complex in D2O buffer (nonexchangeable
proton assignments) at 25°C and in H2O buffer (exchange-
able proton assignments) at 5°C. The starting point in the
assignments of the bound neomycin B protons are the
methylene protons at the 2 position in ring I, which are
unique to this non-sugar 2-deoxystreptamine ring when
compared to the three aminosugar rings II, III and IV
(Figure 1a). The remaining protons on ring I were next
assigned by a combination of through-bond and through-
space connectivities. The assigned H4 proton on ring I
exhibited an NOE to an anomeric proton that was assigned
to H1′ on ring II, which in turn allowed assignment of the
remaining protons on this pyranose ring system. The H5
proton on ring I exhibited an NOE to an anomeric proton
that was assigned to H1′′ on ring III, which in turn allowed
assignment of the remaining protons on this furanose ring
system. The assigned H2′′ and H3′′ protons of furanose
ring III exhibited an NOE to the last anomeric proton that
was assigned to H1′′′ on ring IV, which in turn allowed
assignment of the remaining protons on this pyranose ring
system. The assignments of the bound neomycin
exchangeable protons were next made following analysis of
connectivities to the assigned bound neomycin nonex-
changeable protons of the complex. These include the 
1-NH3+ and 3-NH2 protons on ring I and the 2′-NH3+,
3′-OH, 4′-OH and 6′-NH3+ protons on ring II in the
complex. The exchangeable (5°C) and nonexchangeable
(25°C) proton chemical shifts of the bound neomycin
protons in the complex are listed in Table 1.
Intermolecular distance restraints 
We have identified a set of intermolecular NOEs between
neomycin B and RNA aptamer protons in the complex.
Examples of intermolecular NOEs involving bound RNA
aptamer exchangeable imino protons are shown in an
expanded NOESY (180 ms mixing time) contour plot of
the complex in H2O buffer at 5°C (Figure 2b); examples
of intermolecular NOEs involving bound RNA aptamer
nonexchangeable base protons are shown in an expanded
NOESY (300 ms mixing time) contour plot of the
complex in D2O buffer at 25°C (Figure 2c). A total of 41
intermolecular NOEs have been assigned in the complex
(Table 1). They primarily involve protons on rings I and
II and, to a lesser extent, ring III of bound neomycin in
the complex.
Structure calculations 
The structure calculations were guided by a total of 
337 intramolecular RNA restraints, 41 intramolecular
neomycin B restraints and 41 intermolecular restraints
between the aminoglycoside antibiotic and the RNA
aptamer in the complex (Table 1). Neomycin was posi-
tioned randomly onto each of 100 starting RNA aptamer
folds with randomized backbone torsion angles. A simu-
lated annealing and molecular dynamics computation
guided by the distance restraints was undertaken initially
at 1000K and subsequently at 300K based on the protocol
outlined in the Materials and methods section. Nine dis-
tance-refined structures of the complex were selected
based on the lowest NOE violation and total energies and
subjected to a second round of molecular dynamics calcu-
lations at both high and ambient temperatures. The result-
ing nine distance-refined structures of the complex exhibit
pairwise rmsd values of 1.66 ± 0.36 Å for all residues
(Table 2). The well-defined core of the complex spanning
the binding site (RNA residues U8 to A22 and neomycin B
residues I, II and III) exhibit pairwise rmsd values of
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Table 1
Intermolecular NOEs between neomycin B and RNA aptamer
protons in the complex.
Neomycin B RNA
Ring I (ppm)
H1 3.38 G9(NH1), G10(NH1), U20(NH3), U21(NH3)
1-NH3+ 7.74 G9(NH1), U21(NH3)
H2a 1.78 G9(NH1), U20(NH3), U21(NH3)
H2e 2.57 G9(NH1), G10(NH1), U20(NH3), U21(NH3)
H4 3.29 A16(H2)
H5 3.88 U19(NH3), U20(NH3), U21(NH3)
H6 3.52 A16(H2)
Ring II (ppm)
H1′ 5.07 A16(H2), A16(H1′)
H2′ 3.13 A16(H2), A16(H1′)
2′-NH3+ 7.64 U19(NH3)
H3′ 3.99 G13(NH1), G18(NH1), U19(NH3)
3′-OH 6.60 G13(NH1), U19(NH3)
H4′ 3.18 G13(NH1), A16(H8)
4′-OH 7.23 G13(NH1)
H5′ 3.41 G13(NH1)
H6′ 2.40 A16(H8)
H6′ 2.63 A16(H8)
Ring III (ppm)
H1′′ 5.45 A16(H2)
H2′′ 4.50 A16(H2)
H3′′ 4.54 A16(H2)
H5′′ 3.93 A16(H1′)
H5′′ 4.08 A16(H2), A16(H1′)
Ring IV (ppm)
H1′′′ 5.35 A16(H2)
1.27 ± 0.22 Å (Table 2). Nine superpositioned distance-
refined structures of the neomycin-B–RNA aptamer
complex are shown in Figure 3a. A stereoview of the nine
superpositioned bound neomycin molecules in the
complex is shown in Figure 3b. Two alternative views of a
blow-up of the binding site in one representative refined
structure of the complex are shown in Figures 4a and 4b.
Discussion 
RNA-binding sites for neomycin B
The strong binding site associated with the addition of the
first equivalent of added neomycin B targets an RNA-
binding pocket spanning three consecutive G•U mis-
matches of the G9-G10-G11 and U19-U20-U21 segments
and the flapped base A16 of the RNA aptamer. This con-
clusion is reflected both in complexation proton chemical-
shift changes and the distribution of intermolecular NOE
patterns and was verified following structure determination
of the complex. The weaker binding site associated pri-
marily with the addition of the second equivalent of added
neomycin B targets the adjacent stem region as reflected in
additional downfield chemical-shift changes for specific
stem imino protons on complex formation. We have not
attempted to structurally characterize the RNA aptamer
complex containing two bound neomycin B molecules. It
should be noted that a similar pattern of strong and weak
binding sites located at the zippered-up mismatch aligned
loop and stem segments, respectively, was also observed
for the tobramycin–RNA aptamer complex [21]. 
RNA structure and binding pocket
The structure of the bound RNA is composed of the
Watson–Crick stem segment, a continuous segment con-
taining three consecutive G–U (9•21, 10•20 and 11•19)
mismatches, a Watson–Crick G18•C12 pair, a GAGA
hairpin loop closed by a sheared G13•A17 mispair and a
looped-out A16 base that acts as a flap over the bound
neomycin B. The G9•U21 mismatch and G18•C12 base
pair represent the boundaries of the RNA-binding pocket
with a prominent role for A16 in the encapsulation of a
segment of the bound neomycin B.
The mismatch alignments vary between the three G•U
pairs in the complex. G9•U21 and G10•U20 adopt classical
wobble alignments stabilized by two hydrogen bonds,
whereas the hydrogen bonding is of the bifurcated type
for the G11–U19 mismatch pair in the majority of the
refined structures. There is a relative sliding of adjacent
U8•A22 stem and G9•U21 mismatch pairs that results in a
partial cross-strand overlap between the G9 and A22
purine rings.
The G13•A17 mispair involves the now characteristic
sheared alignment [29–31] of the minor groove edge of the
guanine with the major groove edge of the adenine. The
G13-A14-G15-A17 hairpin loop is of the standard GNRA
type [30,31] with stacking of the N, R and A (A14, G15
and A17 in our case) residues towards the 3′-side of the
adjacent stem segment. The looped-out A16 residue flaps
over the binding pocket.
The bound neomycin B targets the major groove face of
the zippered-up loop segment, which is primarily lined
with acceptor functionalities such as the guanine O6 and
N7 atoms and uracil O4 atoms associated with the three
G•U mismatch pairs. The only donor groups located within
the major groove binding pocket are the cytosine amino
group of the Watson–Crick G18•C12 pair and the guanine
amino group of the sheared G13•A17 mismatch pair.
The looping out of the A16 residue is consistent with the
disruption of the sequential base–sugar H1′ NOE con-
nectivities at the G15-A16 and A16-A17 steps (boxed
regions; Figure 2a) and the unusually upfield-shifted
phosphorus resonance (–6.23 ppm) at the G15-A16 step
in the complex. The RNA aptamer backbone segment
centered about A16 turns inwards towards the major
groove due to this residue flapping over the binding site,
and in the process defines the width of the binding
pocket in the bound RNA aptamer. The looped-out A16
flap residue adopts a C2′-endo pucker (pseudo-rotation
pucker P = 163.9° ± 6.4) and an anti (χ = –94.6° ± 12.9)
glycosidic torsion angle in the neomycin-B–RNA
aptamer complex. By contrast, the corresponding looped-
out flap residue in the tobramycin–RNA aptamer
complex adopts a syn (χ = 53.3 ± 6.0) glycosidic torsion
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Table 2
NMR restraints and structural statistics of the nine refined
structures of the neomycin-B–RNA aptamer complex.
NMR distance restraints 419
RNA aptamer 337
intraresidue 130
interresidue 175
hydrogen bond 32
Neomycin 41
Neomycin–RNA aptamer 41
Structural statistics
Pairwise rmsd values (Å)
RNA (all residues) 1.63 ± 0.36
RNA (residues U8 to A22 only) 1.22 ± 0.23
neomycin B (all residues) 0.81 ± 0.29
neomycin B (rings I, II and III only) 0.36 ± 0.15
complex (all residues) 1.66 ± 0.36
complex (U8 to A22, ring I, II and III only) 1.27 ± 0.22
NOE violations
number >0.2 Å 3.0 ± 1.6
maximum violations (Å) 0.28 ± 0.07
rmsd of violations (Å) 0.038 ± 0.003
Deviations from ideal covalent geometry
bond length (Å) 0.0155 ± 0.0001
bond angles (°) 2.33 ± 0.03
impropers (°) 0.475 ± 0.025
angle, while retaining a C2′-endo (P = 172.5 ± 7.4) sugar
pucker [21].
Neomycin alignment in the binding pocket
Two views of the bound neomycin B in the RNA aptamer
binding pocket are shown in Figure 4a and 4b. Rings I, II
and III  are well defined in contrast to ring IV, which is
poorly defined amongst the solution structures of the
complex (Figure 3b). Neomycin rings I and II are embed-
ded most deeply in the binding pocket and are encapsu-
lated by the A16 flap base; ring IV is directed outwards
towards the solvent. The relative alignments of pyranose
ring II and furanose ring III of neomycin B in the complex
are defined, in part, by a potential intramolecular hydro-
gen bond between the 2′-NH3+ of ring II and the O4′′ of
ring III (N–O distance of 2.78 Å ± 0.13).
The neomycin B was attached randomly through its
primary amine groups to the column for the selection
experiments [23]. There are primary amines at the 6′
position on ring II and at the 6′′′ position on ring IV. We
speculate that the RNA aptamer used in this study most
likely targeted the subset of neomycin B molecules cova-
lently linked through the primary amine at the 6′′′ posi-
tion on exposed ring IV.
Intermolecular interface
Rings I and II of the bound neomycin B in chair confor-
mations are sandwiched between the floor of the major
groove and the flap A16 base in the complex (Figures 4a
and 4b). One face of rings I and II is packed against the
floor of the major groove while the opposite faces of these
rings stack over the aromatic ring of the flap A16 base in
the complex. 
Non-sugar 2-deoxystreptamine ring I is centered about
the G9•U21 and G10•U20 mismatch pairs (Figure 4c) and
hence the majority of the intermolecular NOEs are
between ring I and protons of G9 and G10 on one strand
and U20 and U21 on the opposite strand and the flap A16
base (Table 1). The 1-NH3+ can form potential hydrogen
bonds to the acceptor O4 atoms of U8 and U21 and O6
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Figure 3
Refined structures of the neomycin-B–RNA
aptamer complex and bound neomycin.
(a) Stereoview superposition of nine distance-
refined solution structures of the neomycin-
B–RNA aptamer (A6 to U24) complex. The
RNA bases are colored cyan except for the
mismatched pairs, which are colored green,
and the A16 residue, which is colored
magenta. The RNA backbone is in orange; for
clarity, the exocyclic phosphate oxygens are
not displayed. The bound neomycin is in
yellow. (b) Stereoview superposition of nine
distance-refined solution structures of the
bound neomycin B in the complex. 
atom of G9 (Figure 4c), whereas the 3-NH3+ can form
potential hydrogen bonds to the acceptor N7 atom of G10
(Figure 4c) in the complex.
Pyranose ring II is centered about the G9•U21 mismatch
and Watson–Crick G18•C12 pair (Figure 4d) with the
majority of the intermolecular NOEs between ring II and
protons of G13, G18 and U19 and the flap A16 base
(Table 1). The 2′-NH3+ can form potential hydrogen
bonds to the acceptor O4 atom of U19 and O6 and N7 of
G18 (Figure 4d), whereas the 6′-NH3+ can form potential
hydrogen bonds to the backbone phosphate at the
G9-G10 step (Figure 4d).
The bound neomycin B adopts a U-shaped fold around
the A16 flap base with rings I and II on one face and
poorly defined ring IV on the opposite face of A16. Fura-
nose ring III is positioned approximately in the plane of
A16 with assignable intermolecular NOEs from ring III
protons restricted to the flap A16 base (Table 1). Ring IV
is poorly defined due to the paucity of intermolecular
NOEs for this ring of the bound neomycin B in the
complex (Table 1). 
The 1-NH3+ (7.74 ppm) group on ring I and the 2′-NH3+
(7.64 ppm) and 6′-NH3+ (7.77 ppm) groups on ring II res-
onate in the 7.6 to 7.8 ppm range with their downfield
chemical shifts consistent with protonation of the
neomycin-B–RNA aptamer complex in the pH 6.1 buffer
solution. By contrast, the 3-NH2 (6.48 ppm) group resonates
∼1 ppm to high field of the 7.7 ppm region, consistent with
this amine being unprotonated in the complex under the
same buffer conditions.
The RNA aptamer (Figure 1c) also binds the related amino-
glycoside antibiotic paromomycin but with a >100-fold
reduction in binding affinity relative to neomycin B [23].
The only difference between the two aminoglycoside
antibiotics is that the charged primary amine at the 6′ posi-
tion of ring II in neomycin B is replaced by a hydroxyl
group in paromomycin. This can be understood by our
demonstration that the 6′-NH3+ can form potential hydro-
gen bonds to the backbone phosphates at either the
G9-G10 (in five of the nine refined structures) (Figure 4d)
or G10-G11 (in four of the nine refined structures) steps in
the neomycin-B–RNA aptamer complex. This ionic inter-
molecular interaction would be lost in the corresponding
paromomycin–RNA aptamer complex where the 6′-NH3+
group would be replaced by the 6′-OH group.
Comparison of neomycin B in complex with the 16S RNA 
A-site and RNA aptamer
The solution conformation of bound neomycin B in the
RNA aptamer complex (Figure 5a) can be compared with
the solution conformation of related bound paromomycin
in the A-site 16S rRNA complex (Figure 5b) [6]. Ring IV
of the aminoglycoside antibiotic is least well defined in
both complexes, whereas rings I, II and III adopt similar
conformations in both complexes (Figures 5a and 5b). The
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Figure 4
Intermolecular alignments and hydrogen
bonding. Two orthogonal views of the
neomycin B binding site within the major
groove of the RNA in a representative refined
structure of the neomycin-B–RNA aptamer
complex. The color scheme is the same as in
Figure 3. The neomycin rings I and II are
viewed in (a) a face down orientation and
(b) an edge-wise orientation. Two views of
potential intermolecular hydrogen bonds
between NH3+ groups on neomycin B and
acceptor atoms on the RNA aptamer in the
representative refined structure of the
complex. (c) The 1-NH3+ group on non-sugar
ring I can potentially pair with the O4 acceptor
of U21 and the O6 acceptor of G9. The
3-NH3+ group on non-sugar ring I can
potentially pair with the N7 acceptor of G10.
(d) The 2′-NH3+ group on amino sugar ring II
can potentially pair with the O4 acceptor of
U19 and the O6 and N7 acceptors of G18.
The 6′-NH3+ group on amino sugar ring II can
potentially pair with the exocyclic oxygen of
phosphate at the G9 step. Potential
intermolecular hydrogen bonds are shown by
dashed white lines. 
pairs of inter-ring torsion angles connecting rings I and II,
I and III, and III and IV of bound neomycin B are quite
similar (differences at any particular angle of <15°)
between the two complexes. Thus, neomycin B and
related paromomycin appear to adopt similar conforma-
tions when bound to the distinctly different folds associ-
ated with the binding pockets in the RNA aptamer and
the A-site 16S rRNA complexes [6].
The RNA-binding pockets are very different in the com-
plexes formed between neomycin B and the RNA
aptamer and paromomycin and A-site 16S rRNA [6]. The
pocket in the latter complex is formed by zippering-up an
asymmetric internal loop through U•U and A•A mis-
matches and a bulged adenine base [6], in contrast to the
zippered-up hairpin loop through three G•U mismatches,
a G•C pair and an adenine flap base in the neomycin-
B–RNA aptamer complex. Nevertheless, rings I and II are
bound deep in their respective pockets in both com-
plexes. The amine groups on ring I (our nomenclature)
form hydrogen bonds with base pair edges and backbone
phosphates in both complexes, with fewer such interac-
tions involving rings I and II reported for the paro-
momycin complex [6] relative to the neomycin B
complex. In contrast, both the 3′-OH and 4′-OH groups
on ring II (our nomenclature) are positioned for inter-
action with backbone phosphates only in the paro-
momycin complex [6]. The 3′-OH group on ring II can
form a potential hydrogen bond with the O6 of G18 (O–O
distance of 3.35 Å ± 0.27) in the neomycin-B–RNA
aptamer complex reported in the present study. 
Comparison of the tobramycin and neomycin RNA-binding
pockets
We observe a striking similarity in the principles that
define the architecture of the RNA-binding pockets in the
tobramycin–RNA aptamer [21] and the neomycin-B–RNA
aptamer complexes (Figure 6). The antibiotics bind in the
major groove of a zippered-up mismatched aligned
segment such that non-sugar 2-deoxystreptamine ring I
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Figure 5
Neomycin in complex with the RNA aptamer
and 16S rRNA sites. A comparison of the
conformation of (a) bound neomycin B in the
RNA aptamer complex and (b) bound
paromomycin in the A-site domain of the16S
rRNA complex [6]. The bound neomycin B and
paromomycin are shown in yellow with their
oxygen and nitrogen atoms in red and cyan,
respectively. Differences in the chemical
groups between neomycin B (NH3+ at 6′
position) and paromomycin (OH at 6′ position)
are shown by arrows. The RNA backbone is
shown in orange ribbon representation.
(a) (b)
Structure
Figure 6
RNA aptamer complexes with neomycin B
and tobramycin. A comparison of
representative solution structures of (a) the
neomycin-B–RNA aptamer complex and
(b) the tobramycin–RNA aptamer complex
[21]. The RNA folds are shown in stick and
ribbon representations, with the flapped base
shown in magenta. The bound aminoglycoside
antibiotics are shown as space-filling models.
Rings I and II are colored yellow and red,
respectively; rings III and/or IV are in white.
The white arrows indicate the linkage site
(postulated in the neomycin B complex and
definitive in the tobramycin complex) of the
aminoglycoside antibiotic through its primary
amine moiety to the agarose column.
and one attached pyranose sugar are encapsulated between
the floor and walls of the major groove and a flapped base.
The binding site is anchored at one end by a flanking stem
segment and at the other end by a flanking stable hairpin
loop fold. As each RNA aptamer was screened from a
library of 1014 independent folds, this observed conver-
gence in the architecture of the RNA-binding pocket for
two distinct families of aminoglycoside antibiotics repre-
sents an unanticipated observation. Interestingly, the
observation that tobramycin and neomycin B complexes
with RNA aptamers have a base flapped over the 2-deoxys-
treptamine ring and attached pyranose sugar is highly anal-
ogous to the stacking of aromatic amino acids over sugar
rings in oligosaccharide–protein complexes [32,33].
Biological implications
RNA represents a challenging target for therapeutic
intervention, given the lack of repair mechanisms [3].
The problem has been approached from a chemical per-
spective [14,15,34–36], including combinatorial
approaches for the generation of peptido mimetics [35].
Thus, it has been shown that increasing the charge
through the addition of amino groups and modulating
their basicity can result in an increased affinity for
aminoglycoside antibiotics targeting their RNA-binding
sites [15,17]. Computational approaches to aminoglyco-
side antibiotic–RNA recognition and discrimination
have emphasized the importance of ‘shape selection’,
interfacial water molecules and electrostatic complemen-
tarity between the charged amines on the antibiotic and
the electrostatic potential of RNA-binding pockets
[3,16,17]. Nevertheless, the therapeutic potential of
aminoglycoside antibiotics is limited by the background
activity associated with their propensity to target most
RNA sites with low affinity. Further advances in the
field will require high-resolution views of the shape of the
RNA-binding pockets, the conformations of the bound
aminoglycoside antibiotics and the intermolecular con-
tacts in their high-affinity RNA target sites. Such infor-
mation should help us to identify and analyze the
principles and patterns that define molecular recognition
and discrimination at the atomic level.
The present solution structure of the complex formed
between neomycin B and an RNA aptamer, the solution
structures of two tobramycin–RNA aptamer complexes
[20,21] and the complexes of A-site 16S rRNA with
paromomycin [6] and neomycin [7] have provided our
first high-resolution views of aminoglycoside–RNA com-
plexes. Strikingly, the RNA-binding pockets have
common features for aminoglycoside antibiotic recogni-
tion and discrimination in the three RNA aptamer com-
plexes: the binding cavities are generated by the major
groove edge of a zippered-up mismatch-aligned segment
capped by a flapped base to encapsulate the bound antibi-
otic. The aminoglycoside antibiotics are anchored within
their RNA aptamer binding pockets through a network
of intermolecular hydrogen bonds; bonds are formed
between the charged amine groups of the antibiotic and
acceptor atoms on the base-pair edges and the backbone
phosphates. Such individual intermolecular interactions
account for the ability to discriminate amongst closely
related members of aminoglycoside antibiotic families by
the binding pockets of both natural [6,7] and RNA
aptamer [20,21] targets. The molecular foundation
provided by these structural studies now offers the oppor-
tunity of further optimizing aminoglycoside–RNA recog-
nition and discrimination through a combined chemical,
spectroscopic and computational approach.   
Materials and methods
Sample preparation
The 23-mer RNA aptamer (Figure 1c) was prepared either by chemical
synthesis on an Applied Biosystems synthesizer or by in vitro transcrip-
tion of appropriate synthetic DNA templates using T7 RNA polymerase.
The same transcription conditions were used for the preparation of uni-
formly 13C,15N-labeled RNA aptamers except that 13C,15N-labeled
ribonucleoside triphosphates (rNTPs) were used instead of their unla-
beled counterparts. The RNA oligomers were ethanol precipitated and
purified as described previously [21]. NMR samples at a concentration
of 3 mM in RNA aptamer were prepared in 10 mM phosphate buffer
solution at pH 6.1.
Neomycin sulfate was purchased from Sigma and used without further
purification. A neomycin stock solution (75 mM) was prepared by dis-
solving the aminoglycoside antibiotic in an aqueous solution adjusted
to pH 6.1. This neomycin stock solution was gradually added to the
RNA aptamer and complex formation followed by recording imino
proton spectra.
NMR spectroscopy
NMR spectra were collected on Varian Unity Inova 500 MHz, 600 MHz
and 800 MHz NMR spectrometers. A detailed description of the multin-
uclear multidimensional NMR experiments used for data collection have
been outlined in previous contributions from our laboratory on ligand-
RNA aptamer complexes [21]. In addition, 13C-edited aromatic-sugar
NOESY experiments (to be published elsewhere) were carried to
resolve severe overlap of resonances associated with the long stem
region of the RNA aptamer. The NMR data were processed on SUN
work stations using VNMR software and analyzed using the FELIX
program (Molecular Simulations Inc). The three-dimensional (3D) NMR
data were processed using NMRPipe [37] and PIPP [38] programs.
Proton chemical shifts were referenced to 2,2-dimethyl-2-silapentane-
5-sulfonate (DSS) while carbon and nitrogen chemical shifts were indi-
rectly referenced to DSS and ammonia, respectively.
Input restraints
Interproton distances were obtained from cross-peak intensities in
NOESY spectra of the complex in H2O buffer (mixing times 50 ms,
100 ms and 200 ms at 5°C) and D2O buffer (mixing times 50 ms and
120 ms at 25°C). Distance restraints in H2O buffer were calibrated
against the uracil imino to the adenine H2 distance of 2.93 Å and
given a bounds range of ± 30%. The bounds were increased for
restraints involving amino protons and overlapped cross-peaks. Dis-
tance restraints in D2O buffer were calibrated using uracil H5-H6 as
a reference distance of 2.45 Å and were imposed with bounds of
± 30% of the calculated distance. The bounds were increased for
restraints involving adenine H2 protons and overlapped cross-peaks.
Very weak cross-peaks observed in a long mixing time (300 ms)
NOESY data set in D2O buffer at 25°C were given a bounds range of
1.8 to 6.5 Å. In addition, intensities of cross-peaks in a 3D NOESY-
HMQC data set (120 ms mixing time) recorded in D2O buffer at
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25°C were analyzed qualitatively and classified as strong (1.8–3.5 Å),
medium (1.8–5.0 Å) and weak (1.8A–6.5 Å). The same qualitative
bounds ranges were applied for additional distance restraints
obtained from 13C-selective NOESY experiments. Hydrogen-bonding
restraints were imposed only on the regular Watson–Crick base pairs
G4•C26, G5•C25, A6•U24, C7•G23, U8•A22 and C12•G18
whose alignments were established experimentally. The only sugar
pucker restraint involved the A16 residue which was assigned a
C2′-endo pucker based on its strong H1′-H2′ cross-peak in a phase-
sensitive COSY experiment. 
Structural calculations
A set of 100 RNA aptamer starting structures were generated with ran-
domized backbone torsion angles. Neomycin B was then positioned ran-
domly onto each starting RNA aptamer fold to generate 100 starting
structures of the complex. These structures were subjected to simulated
annealing and restrained molecular dynamics protocols using the
X-PLOR 3.1 program [39]. The first stage of the structure calculations
began with 500 cycles of initial energy minimization. Next, the force con-
stants for the distance restraints and repulsive-only van der Waals poten-
tial were gradually increased over 14 cycles of 1 ps restrained molecular
dynamics at 1000K. The final force constants were the following:
knoe = 50 kcal mol–1 A–2, kcdih (dihedral restraints) = 50 kcal mol–1 rad–2
and rcon(vdW) = 0.1 kcal mol–1A–4. The system was next gradually
cooled to 300K over 35 cycles of 0.5 ps dynamics followed by
1000 cycles of energy minimization.
These first stage computations undertaken with repulsive only van der
Waals potential yielded a set of nine structures that were selected
based on total energy values <155 kcal mol–1 and NOE energy values
of < 5 kcal mol–1. In these structures, G15 was stacked on A14 at the
tip of the loop. Another set of 21 structures had total energy values
>175 kcal mol–1 and NOE energy values of >15 kcal mol–1. The inter-
molecular alignments remained essentially the same but the G15 base
was tilted relative to A14 in these higher total and NOE energy subset
of structures. 
The nine structures with the lowest NOE violation energies and
lowest total energies were chosen for further refinement. The weights
for both distance and dihedral restraints were maintained as before,
while the intermolecular nonbonded interactions were gradually
reduced in weight from 1.0 to 0.1 over 500 cycles of minimization.
The system was then heated gradually from 300K to 1000K over
14 cycles of 0.5 ps dynamics. While at 1000K, the electrostatic
potential and the attractive term of the Lennard–Jones potential
between the RNA aptamer and neomycin B were gradually increased
from the weight of 0.1 to 1.0. The system was next slowly cooled to
300K over 14 cycles of 0.5 ps dynamics and was maintained at
300K for an additional 12 ps of dynamics. The resulting structures
were subsequently minimized.
Structure analysis
The RNA helical parameters were analyzed using the CURVES
program [40]. Color figures were prepared using INSIGHT II (Molecu-
lar Simulations, Inc) and GRASP [41] programs.
Accession numbers
The coordinates of the complex formed between neomycin B and the
RNA aptamer have been deposited with the Protein Data Bank (acces-
sion number 1nem).
Supplementary material
Supplementary material available with the internet version of this paper
contains three tables of chemical-shift values obtained for the
neomycin–RNA aptamer complex and one table comparing inter-ring
torsion angles of the bound aminoglycoside antibiotics in the
neomycin–RNA aptamer and paramomycin–16S RNA complexes. In
addition, there are 11 figures showing the heteronuclear multidimen-
sional NMR spectra of the neomycin–RNA aptamer complex.
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S1Supplementary material
Table S1
RNA proton chemical shifts (ppm) in the neomycin-B–RNA aptamer complex*.
Imino Amino H8/H6 H5/H2 H1′ H2′ H3′ H4′ H5′,H5′′†
G4 7.91 5.76 4.83 4.78 4.54 4.39,4.25
G5 12.54 7.58 5.71 4.62 4.56 4.56 4.46,4.30
A6 6.64,8.23 7.90 7.81 6.01 4.58 4.66 4.52 4.63,4.17
C7 7.11,8.48 7.42 5.21 5.44 4.32 4.38 4.40 4.02,4.50
U8 13.40 7.81 5.42 5.66 4.45 4.63 4.52 4.12,4.52
G9 10.22 6.49 8.04 5.96 4.73 4.56 4.57 4.60,4.19
G10 11.10 6.23 7.16 5.81 4.54 4.58 4.47 4.00,4.55
G11 11.53 6.74 7.34 5.75 4.44 4.44 4.44 4.58,4.10
C12 7.26,8.29 7.21 4.98 5.57 4.35 4.35 4.35 4.12,4.42
G13 10.89 5.73,7.80 7.69 5.55 4.32 4.81 4.34 4.16,4.34
A14 7.98 7.80 5.58 4.30 4.38 4.18 4.25,3.87
G15 7.44 5.54 4.09 4.90 4.25 4.27,3.89
A16 8.69 8.24 6.19 5.00 4.77 4.64 4.58,4.15
A17 7.42 8.27 6.06 5.20 3.92 4.61 4.71,4.01
G18 13.62 6.61,8.74 7.46 4.31 4.45 4.27 4.37 4.11,4.41
U19 12.31 7.79 5.16 5.46 4.33 4.38 4.39 4.02,4.58
U20 12.56 8.19 5.61 5.57 4.18 4.57 4.38 4.09,4.58
U21 11.71 7.96 5.66 5.57 4.40 4.63 4.38 4.53,4.05
A22 6.55,7.50 8.19 6.92 5.82 4.63 4.56 4.49 4.20,4.52
G23 13.25 6.36,8.59 7.01 5.43 4.41 4.26 4.42 4.34,4.00
U24 14.46 7.77 5.02 5.57 4.53 4.43
C25 6.96,8.42 7.85 5.65 5.59 4.27 4.43 4.54,4.08
C26 7.68 5.56 5.72 3.98 4.18 4.18 4.03,4.50
*Imino and amino protons (5°C) and nonexchangeable protons (25°C) of the complex in 10 mM phosphate buffer at pH 6.1. †H5′ and H5′′ proton
assignments are non-stereospecific.
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Table S2
RNA carbon and nitrogen chemical shifts (ppm) in the
neomycin-B–RNA aptamer complex*.
N1/N3 C8/C6 C5/C2 C1′ C2′ C3′ C4′ C5′
G4 138.47 91.32 75.7 75.0 83.7 67.5
G5 147.22 137.14 93.07 75.8 73.9 82.8 67.7
A6 139.40 154.02 93.08 75.9 72.8 82.2 65.0
C7 140.66 97.38 93.67 76.0 72.5 82.0 65.0
U8 162.95 141.50 104.57 93.59 76.3 73.2 82.5 65.3
G9 141.31 138.46 92.49 75.5 72.9 82.1 65.6
G10 143.21 136.74 93.15 75.5 72.5 82.1 64.5
G11 144.27 137.30 93.25 75.7 72.1 82.7 64.6
C12 138.80 98.60 93.85 76.5 72.3 82.2 64.3
G13 137.46 93.73 75.8 71.7 82.6 64.7
A14 141.80 154.02 93.92 75.5 72.2 83.2 63.7
G15 137.71 93.71 77.5 74.0 84.0 65.2
A16 141.89 155.85 86.77 75.0 77.5 85.9 69.0
A17 139.39 155.35 94.04 75.3 75.7 84.0 70.3
G18 147.42 136.21 92.41 75.20 72.5 82.1 64.8
U19 158.43 141.37 104.19 94.42 75.7 72.5 82.5 64.00
U20 157.94 142.14 104.27 93.85 76.2 75.8 82.6 64.2
U21 157.45 142.14 104.51 92.96 75.2 73.2 82.5 64.2
A22 140.39 153.05 92.74 76.3 73.9 82.5 66.5
G23 148.35 136.10 93.17 75.5 73.8 82.7 67.0
U24 163.10 141.99 102.89 94.2 75.5 72.4 82.5
C25 141.60 97.76 94.5 75.8 72.8 64.9
C26 141.89 98.38 93.12 77.8 70.1 83.8 65.5
*Imino nitrogens (5°C) and carbons (25°C) of the complex in 10 mM
phosphate buffer at pH 6.1.
Table S3
Proton assignments of neomycin in the neomycin–RNA
aptamer compex*.
Ring I Ring II Ring III Ring IV
H1 3.38 H1′ 5.07 H1′′ 5.45 H1′′′ 5.35
1-NH3+ 7.74 H2′ 3.13 H2′′ 4.50 H2′′′ 3.60
H2a 1.78 2′-NH3+ 7.64 H3′′ 4.54 H3′′′ 4.23
H2e 2.57 H3′ 3.99 H4′′ 4.27 H4′′′ 3.83
H3 3.49 3′-OH 6.60 H5′′ 3.93, 4.08 H5′′′ 4.33
3-NH2 6.48 H4′ 3.18 H6′′′ 3.33,3.46
H4 3.29 4′-OH 7.23
H5 3.88 H5′ 3.41
H6 3.52 H6′ 2.40, 2.63
6′-NH3+ 7.77
*Exchangeable (5°C) and nonexchangeable protons (25°C) of the
complex in 10 mM phosphate at pH 6.1.
Table S4
Comparison of the inter-ring torsion angles of neomycin B in
the RNA aptamer complex and of paromomycin in the 16S
rRNA complex.
Neomycin–RNA Paromomycin–16S
aptamer rRNA
II(H1′)-II(C1′)-O-I(C4) –49.6° ± 4.6 –34.7°
II(C1′)-O-I(C4)-I(H4) –25.0° ± 4.4 –26.8°
I(H5)-I(C5)-O-III(C1′′) 12.6° ± 4.4 –2.7°
I(C5)-O-III(C1′′)-III(H1′′) 13.4° ± 9.3 0.0°
III(H3′′)-III(C3′′)-O-IV(C1′′′) –18.7° ± 19.0 –3.0°
III(C3′′)-O-IV(C1′′′)-IV(H1′′′) –54.1° ± 5.7 –63.0°
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Figure s1
An expanded NOESY (200 ms mixing time) contour plot of the
symmetrical imino proton region (9.7–14.9 ppm) of the neomycin-
B–RNA aptamer complex in H2O buffer at pH 6.1 and 5°C. The lines
trace the NOE connectivities between imino protons on adjacent base
pairs along the stem segments of the RNA aptamer in the complex.
Figure s2
An expanded NOESY (200 ms mixing time)
contour plot identifying NOEs between the
imino protons (9.7–14.9 ppm) and the amino,
base and some neomycin B protons (5.2 to
9.1 ppm) in the neomycin-B–RNA complex in
H2O buffer at pH 6.1 and 5°C. The intra-RNA
NOE cross-peaks are labeled by numbers and
assigned as follows: 1, U24(NH3)-A6(H2);
2b,e, U24(NH3)-A6(NH2-6b,e); 3b,e,
G18(NH1)-C12(NH2-4b,e); 4b,e, G18(NH1)-
G18(NH2-2b,e); 5, U8(NH3)-A22(H2); 6b,e,
U8(NH3)-A22(NH2-6b,e); 7b,e,  G23(NH1)-
C7(NH2-4b,e); 8b,e, G23(NH1)-G23(NH2-
2b,e); 9, G23(NH1)-A6(H2); 10, G23(NH1)-
A22(H2); 11, U20(NH3)-G10(NH2-2b,e); 12,
U20(NH3)-G11(NH2-2b,e); 13b,e, G5(NH1)-
C25(NH2-4b,e); 14, U19(NH3)-G11(NH2-
2b,e); 15b,e, U19(NH3)-C12(NH2-4b,e); 16,
U21(NH3)-G9(NH2-2b,e); 17, G11(NH1)-
G11(NH2-1b,e); 18b,e, G10(NH1)-
G10(NH2-2b,e); 19, G13(NH1)-A17(H8); 20,
G9(NH1)-G9(NH2-2b,e); 21, G9(NH1)-
A22(H8). The intermolecular NOE cross-
peaks are labeled by lower-case letters and
assigned as follows: a, U19(NH3)-II(NH2-2′);
b, U21(NH3)-I(NH2-1); c, G13(NH1)-II(NH2-
2′); d, G13(NH1)-II(OH-4′); e, G13(NH1)-
II(OH-3′).
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Figure s3
An expanded JNN HNN-COSY contour plot correlating two bond
coupling connectivities between donor and acceptor nitrogens within
N-H–N hydrogen bond alignments across mismatch pairs in the
complex containing neomycin B and uniformly 13C,15N-labeled RNA
aptamer in H2O buffer at pH 6.1 and 5°C. The labeled cross peaks
identify uracil N1H to adenine N1 coupling connectivities across
Watson—Crick A•T base pairs and guanine N1H to cytosine N3
coupling connectivities across Watson—Crick G•C base pairs. The
one-dimensional imino proton spectrum is shown with assignments
over the contour plot.
Figure s4
An expanded contour plot of a two-
dimensional version of the 1H-13C HMQC-
NOESY (150 ms mixing time) experiment
identifying correlations between imino protons
and adenine C2 and base C6/C8 carbons in
the neomycin B-13C,15N-labeled RNA aptamer
complex in H2O buffer at pH 6.1 and 5°C.
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Figure s5
An expanded contour plot of (a) 1H-15N HSQC spectrum correlating
imino proton and attached nitrogen regions of the neomycin B-
13C,15N-labeled RNA aptamer complex in H2O buffer at pH 6.1 and
5°C. An expanded contour plot of (b) a two-dimensional version of the
1H-15N HMQC-NOESY (150 ms mixing time) experiment identifying
correlations between imino protons and attached nitrogens in the
neomycin B-13C,15N-labeled RNA aptamer complex in H2O buffer at
pH 6.1 and 5°C. NOE cross-peaks are identified in the contour plots.
Figure s6
A plot of two-dimensional 1H-1H spectral
strips at specific purine C8/pyrimidine C6
carbon chemical shift values taken from the
three-dimensional 1H-13C NOESY-HMQC
(300 ms mixing time) experiment on the
neomycin B-13C,15N-labeled RNA aptamer
complex in D2O buffer, pH 6.1 at 25°C. The
lines trace NOE connectivities between base
protons and their own and 5′-flanking sugar
H1′ protons from U8 to A22 in the bound
RNA aptamer in the complex.
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Figure s7
An expanded contour plot of the proton-detected phosphorus-proton
heteronuclear correlation experiment on the neomycin-B–RNA aptamer
complex in D2O buffer, pH 6.1 at 25°C. Phosphorus chemical shifts
are referenced relative to external trimethylphosphate (TMP) standard.
The phosphorus to their H3′ proton correlations are boxed in the
contour plot. The one-dimensional proton-decoupled phosphorus
spectrum (–0.75– –6.50 ppm) is shown with available phosphorus
assignments over the contour plot. 
Figure s8
(a) An expanded 1H-13C constant time HSQC contour plot identifying
one-bond 1H-13C correlations between bound RNA pyrimidine H5
protons and their attached carbons in the neomycin B-13C,15N-labeled
RNA aptamer complex in D2O buffer, pH 6.1 at 25°C. (b) An
expanded natural abundance 1H-13C HMQC contour plot identifying
one bond 1H-13C correlations between bound neomycin B anomeric
protons and their attached carbons (boxed cross-peaks) and bound
RNA pyrimidine H5 protons and their attached carbons in the
neomycin-B–RNA aptamer complex in D2O buffer, pH 6.1 at 25°C.
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Figure s9
(a) An expanded NOESY (180 ms mixing time) contour plot identifying
NOEs between neomycin B exchangeable (6.3–7.9 ppm) and
nonexchangeable protons (1.5–4.5 ppm) in the neomycin-B–RNA
aptamer complex in H2O buffer at pH 6.1 and 5°C. (b) An expanded
TOCSY (45 ms spin lock time) contour plot identifying correlation
peaks between neomycin B exchangeable (6.3–7.9 ppm) and
nonexchangeable protons (1.5–4.5 ppm) in the neomycin-B–RNA
aptamer complex in H2O buffer at pH 6.1 and 5°C.
Figure s10
A TOCSY (50 ms spin lock time) contour plot of the neomycin-B–RNA
aptamer complex in D2O buffer, pH 6.1 at 25°C showing the through
bond correlations of the H2a and H2b protons on ring I with other
protons within the same ring system. 
Figure s11
(a) An expanded 13C-filtered NOESY (300 ms mixing time) contour
plot of the neomycin B-13C,15N-labeled RNA aptamer complex in D2O
buffer, pH 6.1 at 25°C. The NOE connectivities are shown between
the H1′, H1′′, and H1′′′ protons and other bound neomycin B protons
on the same and adjacent ring systems. The boxed cross-peaks
identify NOEs between protons on adjacent ring systems. (b) An
expanded COSY contour plot identifying coupling correlations
between bound neomycin B H1′, H1′′ and H1′′′ protons and H2′, H2′′
and H2′′′ protons within individual ring systems in the neomycin-
B–RNA aptamer complex in D2O buffer, pH 6.1 at 25°C.
